Biotech news for Thursday, June 4, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Md Saiful Islam Khan/iStock via Getty Images TG Therapeutics ( TGTX ) added more than 10% on Wednesday after data from an early-stage trial evaluating a subcutaneously delivered version of its top-selling drug, Briumvi, supported a quarterly dosing regimen cur…
Protean Small Cap gained 5.7% in May, outperforming the Carnegie Nordic Small-Cap Index's 3.3% return. Meanwhile, Protean Select returned 1.4% in May, while Protean Aktiesparfond Norden gained 3.2%, trailing its benchmark index's 4.0% rise. The fund initiated…
alexsl Rezolute ( RZLT ) traded higher for the third straight session on Wednesday after Citizens JMP Securities upgraded the stock, highlighting a recent late-stage trial update the company shared for its lead asset, ersodetug. Shares of the rare-disease drug…
IDEAYA Bioscience ( IDYA ) and Roche ( RHHBY ) have agreed to jointly evaluate a combination of the former's IDE892 with the latter's RG6505 for MTAP-deleted RAS-mutant pancreatic cancer. Both assets are in phase 1. IDE892 is an MTA-cooperative PRMT5 inhibitor…
CytomX Therapeutics ( CTMX ) traded higher in the morning hours on Wednesday after the cancer drug developer announced an expanded collaboration and licensing agreement with Regeneron Pharmaceuticals ( REGN ) valued up to $4B. Two companies initially teamed up…
Short interest data from late May indicates varying investor feelings in the healthcare sector, with strong bearish bets concentrated on micro- and small-cap biotechnology names like Quantum Cyber ( QUCY ) and Sensei Biotherapeutics ( SNSE ). Meanwhile, niche…
iQoncept/iStock via Getty Images Short interest data from late May indicates varying investor feelings in the healthcare sector, with strong bearish bets concentrated on speculative biotech plays like Recursion Pharmaceuticals ( RXRX ) and Hims & Hers ( HI…
Liminatus Pharma ( LIMN ) has entered into a warrant exercise agreement to exercise certain outstanding warrants to purchase an aggregate of 10.34M shares of common stock of the company for gross proceeds of $1.9M. In consideration for the immediate exercise o…
LIXTE Biotechnology Holdings ( NASDAQ: LIXT ) on Wednesday said it entered into definitive agreements with accredited investors for a registered direct offering expected to raise approximately $16.6 million in gross proceeds. The offering consists of 2.63 mill…
Celcuity ( NASDAQ: CELC ) on Wednesday said that it plans to offer $400 million of convertible senior notes due 2032 in an underwritten public offering. The clinical-stage biotechnology company said it expects to grant underwriters a 30-day option to purchase…
Restart Life Sciences ( NMLSF ) has appointed Inez Ho as CFO, effective immediately. Ho succeeds Rebecca Hudson, who has resigned from her role to pursue other commitments. Bringing over 12 years of corporate compliance, financial reporting, and capital market…
Mineralys Therapeutics ( MLYS ) has priced an offering of 5.66M shares of its common stock at a price of $26.50 per share. The gross proceeds from the offering are expected to be around $150M. Mineralys plans to use the net proceeds to fund a
Tang Capital Management Tuesday said that it acquired 206,005 common shares of Aurinia Pharmaceuticals ( AUPH ) at a price of $15.28 per share for an aggregate purchase price of $3.1M. As a result of the purchase, Tang Capital Management, LLC beneficially owns…
narvo vexar The US FDA has issued draft guidance intended to accelerate the development of gene and cell therapies. The agency hopes the document will enhance the R&D process for the treatments " by making greater use of existing scientific and regulatory
Amgen ( AMGN ) has received marketing authorization from the European Commission to market its FDA-approved antitumor agent Imdelltra, also known as tarlatamab, as a late-line option in the EU for adults with certain types of small cell lung cancer. Specifical…